IDEAYA Biosciences, Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IDEAYA Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • IDEAYA Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 4.25 %, a 40.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 4.25 -2.86 -40.3% Sep 30, 2024
Q2 2024 4.05 -4.8 -54.2% Jun 30, 2024
Q1 2024 4.1 -9.54 -69.9% Mar 31, 2024
Q4 2023 5.6 -11.6 -67.4% Dec 31, 2023
Q3 2023 7.11 -14.1 -66.5% Sep 30, 2023
Q2 2023 8.85 -16.7 -65.3% Jun 30, 2023
Q1 2023 13.6 -14.2 -51.1% Mar 31, 2023
Q4 2022 17.2 -14.2 -45.2% Dec 31, 2022
Q3 2022 21.2 -15.5 -42.1% Sep 30, 2022
Q2 2022 25.5 -19.1 -42.8% Jun 30, 2022
Q1 2022 27.9 -11.1 -28.5% Mar 31, 2022
Q4 2021 31.4 -3.92 -11.1% Dec 31, 2021
Q3 2021 36.7 +10.9 +42.2% Sep 30, 2021
Q2 2021 44.6 +34.1 +324% Jun 30, 2021
Q1 2021 39 +27.1 +228% Mar 31, 2021
Q4 2020 35.3 Dec 31, 2020
Q3 2020 25.8 Sep 30, 2020
Q2 2020 10.5 Jun 30, 2020
Q1 2020 11.9 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.